Shelby Smith
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 27.8% of the total. 2025 is the largest year on record at $862, 5.1 times the $169 reported in 2021.
Across 117 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$566
- Pfizer$249
- Takeda Pharmaceuticals U.S.A., Inc.$236
- Celltrion USA Inc.$127
- Johnson & Johnson$103
- Aimmune Therapeutics, Inc.$91
- plus $666 from 17 others
What the payments were for
- Food & beverage$2,01699%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,039 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Other family in Plano
- Kori NelsonPlano$148K
- Zaineb ShamsPlano$64K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.